Company news
Pulike Biological Engineering, Inc. news in 2026
Pulike Biological Engineering, Inc.'s news releases, calls and decks from 2026, newest first.
(603566)"Pulike Biological Engineering, Inc."Report for Q3 2026
October 26, 2026
(603566)"Pulike Biological Engineering, Inc."Announcement on Convening the Q3 2026 Performance Briefing
October 26, 2026
(603566)"Pulike Biological Engineering, Inc."Announcement on Obtaining the Approval for the Clinical Trial of Veterinary Biological Products
October 12, 2026
Announcement on Change of Sponsor Representative for Continuous Supervision and Guidance
September 15, 2026
Announcement on Obtaining New Veterinary Drug Registration Certificate by Subsidiary
September 14, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
August 24, 2026
Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
August 20, 2026
Announcement on the Controlled Subsidiary Being Approved to Produce Foot-and-Mouth Disease Vaccine (SAT 1)
July 21, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
June 30, 2026
Announcement on Terminating Some Investment Projects Financed by Raised Funds
June 14, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 8, 2026
Announcement on Obtaining New Veterinary Drug Registration Certificate
June 5, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 21, 2026
Announcement on Applying to Bank for Comprehensive Credit Line
April 28, 2026
Announcement on Resolutions of the 1st Meeting of the 6th Board of Directors
March 6, 2026
Announcement on Resolutions of the 23rd Meeting of the 5th Board of Directors
February 6, 2026
Earnings Preannouncement for 2025
January 20, 2026
Announcement on Estimated Daily Related Party Transactions in 2026
January 15, 2026
Announcement on Subsidiary Obtaining New Veterinary Drug Registration Certificate
January 13, 2026